MB
Therapeutic Areas
Curtana Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CT-179 | Glioblastoma (recurrent and newly diagnosed) | Phase 1 |
Leadership Team at Curtana Pharmaceuticals
GS
Gregory Stein, M.D., M.B.A.
Chief Executive Officer
DS
Dr. Santosh Kesari
Scientific Founder / Advisor